A549 cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SRF | hg19_v2_chr6_+_43139037_43139094 | 0.73 | 1.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_56179262 Show fit | 0.67 |
ENST00000606639.1
|
RP11-481J13.1 |
|
chr22_-_36850991 Show fit | 0.64 |
ENST00000442579.1
|
RP5-1119A7.14 |
|
chr12_+_54426637 Show fit | 0.50 |
ENST00000312492.2
|
homeobox C5 |
|
chr9_+_92219919 Show fit | 0.48 |
ENST00000252506.6
ENST00000375769.1 |
growth arrest and DNA-damage-inducible, gamma |
|
chr8_+_97597148 Show fit | 0.43 |
ENST00000521590.1
|
syndecan 2 |
|
chr4_+_87928140 Show fit | 0.42 |
ENST00000307808.6
|
AF4/FMR2 family, member 1 |
|
chr11_-_65626797 Show fit | 0.41 |
ENST00000525451.2
|
cofilin 1 (non-muscle) |
|
chr3_+_187930491 Show fit | 0.39 |
ENST00000443217.1
|
LIM domain containing preferred translocation partner in lipoma |
|
chr19_+_16177826 Show fit | 0.39 |
ENST00000589897.1
|
tropomyosin 4 |
|
chr19_-_35166604 Show fit | 0.34 |
ENST00000601241.1
|
secretoglobin, family 2B, member 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.8 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.7 | GO:0071964 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.0 | 0.7 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.4 | GO:2001113 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
0.1 | 0.4 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.4 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.0 | 0.4 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.0 | 0.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.2 | GO:0060532 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.7 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.3 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.3 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.2 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.0 | 0.2 | GO:0031523 | Myb complex(GO:0031523) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 0.2 | GO:0010736 | serum response element binding(GO:0010736) |
0.0 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.0 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0090541 | MIT domain binding(GO:0090541) |
0.0 | 0.1 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.0 | 0.1 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.5 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |